Multiple sclerosis in a young woman with sickle cell disease
Copyright © 2020 Elsevier B.V. All rights reserved..
BACKGROUND: Comorbidities can impose diagnostic and treatment challenges in patients with multiple sclerosis (MS). Sickle cell disease (SCD) and MS are both inflammatory diseases featuring immune system dysregulation, and the reciprocal interaction of these diseases deserves investigation.
METHODS/RESULTS: We present the case of a 28-year-old woman with SCD who developed a sickle cell crisis and acute chest syndrome during corticosteroid treatment for a first MS attack. We then provide a review of the literature on co-management of SCD and MS. In patients with SCD experiencing an acute MS exacerbation, pre-treatment with red blood cell exchange transfusion before corticosteroids may reduce adverse vaso-occlusive events. Plasma exchange may also be considered. Finally, we discuss innovative pre-clinical research that suggests that natalizumab or dimethyl fumarate may ameliorate SCD symptoms while preventing MS relapses; human trials, however, are needed.
CONCLUSION: The co-occurrence of inflammatory disorders, in this case MS and SCD, requires providers to appropriately manage each condition with consideration of the other. Future studies may generate shared avenues for treatment.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:45 |
|---|---|
| Enthalten in: |
Multiple sclerosis and related disorders - 45(2020) vom: 20. Okt., Seite 102427 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kerpen, Kate [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
African american |
|---|
| Anmerkungen: |
Date Completed 14.05.2021 Date Revised 14.05.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.msard.2020.102427 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM314152385 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM314152385 | ||
| 003 | DE-627 | ||
| 005 | 20231225152124.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.msard.2020.102427 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1047.xml |
| 035 | |a (DE-627)NLM314152385 | ||
| 035 | |a (NLM)32841868 | ||
| 035 | |a (PII)S2211-0348(20)30502-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kerpen, Kate |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Multiple sclerosis in a young woman with sickle cell disease |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.05.2021 | ||
| 500 | |a Date Revised 14.05.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020 Elsevier B.V. All rights reserved. | ||
| 520 | |a BACKGROUND: Comorbidities can impose diagnostic and treatment challenges in patients with multiple sclerosis (MS). Sickle cell disease (SCD) and MS are both inflammatory diseases featuring immune system dysregulation, and the reciprocal interaction of these diseases deserves investigation | ||
| 520 | |a METHODS/RESULTS: We present the case of a 28-year-old woman with SCD who developed a sickle cell crisis and acute chest syndrome during corticosteroid treatment for a first MS attack. We then provide a review of the literature on co-management of SCD and MS. In patients with SCD experiencing an acute MS exacerbation, pre-treatment with red blood cell exchange transfusion before corticosteroids may reduce adverse vaso-occlusive events. Plasma exchange may also be considered. Finally, we discuss innovative pre-clinical research that suggests that natalizumab or dimethyl fumarate may ameliorate SCD symptoms while preventing MS relapses; human trials, however, are needed | ||
| 520 | |a CONCLUSION: The co-occurrence of inflammatory disorders, in this case MS and SCD, requires providers to appropriately manage each condition with consideration of the other. Future studies may generate shared avenues for treatment | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a African american | |
| 650 | 4 | |a Anemia | |
| 650 | 4 | |a Blood transfusion | |
| 650 | 4 | |a Comorbidity | |
| 650 | 4 | |a Multiple sclerosis | |
| 650 | 4 | |a Plasma exchange | |
| 650 | 4 | |a Sickle Cell | |
| 700 | 1 | |a Baptiste, Ayanna |e verfasserin |4 aut | |
| 700 | 1 | |a Yeshokumar, Anusha K |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Multiple sclerosis and related disorders |d 2012 |g 45(2020) vom: 20. Okt., Seite 102427 |w (DE-627)NLM219118388 |x 2211-0356 |7 nnns |
| 773 | 1 | 8 | |g volume:45 |g year:2020 |g day:20 |g month:10 |g pages:102427 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.msard.2020.102427 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 45 |j 2020 |b 20 |c 10 |h 102427 | ||